Tg Therapeutics reported $1.62M in Interest Expense on Debt for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Interest Expense On Debt Change
Amgen AMGN:US $ 281M 4M
Ardelyx ARDX:US $ 1.2M 0.1M
Arena Pharmaceuticals ARNA:US $ 1.05M 0.02M
Biogen BIIB:US $ 56.4M 8.3M
Dynavax Technologies DVAX:US $ 3.11M 1.6M
Gilead Sciences GILD:US $ 256M 1M
Intercept Pharmaceuticals ICPT:US $ 12.59M 0.17M
Karyopharm Therapeutics KPTI:US $ 5M 94K
Novartis NOVN:VX 201M 1000K
Novavax NVAX:US $ 5.97M 1.13M
Ptc Therapeutics PTCT:US $ 22.56M 2.7M
Puma Biotechnology PBYI:US $ 3.52M 0.07M
Regeneron Pharmaceuticals REGN:US $ 14.4M 0.2M
Tg Therapeutics TGTX:US $ 1.62M 0.28M
Verastem VSTM:US $ 1.01M 0.03M
Vertex Pharmaceuticals VRTX:US $ 15.48M 0.2M